Ortin Global Ltd. logo

Ortin Global Ltd. (ORTINGLOBE)

Market Closed
11 Aug, 10:00
XNSE XNSE
15. 14
+0.51
+3.486%
174.18M Market Cap
- P/E Ratio
- Div Yield
7,644 Volume
- Eps
14.63
Previous Close
Add Transaction
Day Range
14.7 15.25
Year Range
10.66 21.3
Want to track ORTINGLOBE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ORTINGLOBE closed today higher at ₹15.14, an increase of 3.486% from yesterday's close, completing a monthly increase of 3.6986% or ₹0.54. Over the past 12 months, ORTINGLOBE stock gained 11.3235%.
ORTINGLOBE is not paying dividends to its shareholders.
The last earnings report, released on May 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Ortin Global Ltd. has completed 1 stock splits, with the recent split occurring on Jan 12, 2021.
The company's stock is traded on one exchange.

ORTINGLOBE Chart

Ortin Global Ltd. (ORTINGLOBE) FAQ

What is the stock price today?

The current price is ₹15.14.

On which exchange is it traded?

Ortin Global Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is ORTINGLOBE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 174.18M.

Has Ortin Global Ltd. ever had a stock split?

Ortin Global Ltd. had 1 splits and the recent split was on Jan 12, 2021.

Ortin Global Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Sanka Murali Krishna Murthy CEO
XNSE Exchange
Y6495A125 CUSIP
India Country
2 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Ortin Global Limited, previously known as Ortin Laboratories Limited until June 2024, is a firm rooted in the pharmaceutical sector based in Hyderabad, India. Founded in 1986, the company has built its repute in the manufacture and trading of pharmaceuticals, drugs, and intermediates. It extends its offerings across India, focusing on the development, production, and distribution of a wide array of pharmaceutical formulations and active pharmaceutical ingredient (API) intermediates, as well as fine chemicals. Ortin Global is also engaged in providing a spectrum of services that encompass process development, analytical research, and diagnostic solutions. Beyond its manufacturing capabilities, it acts as a merchant exporter of pharmaceutical finished formulations, while also engaging in long-term contracts for the development of new APIs and the manufacturing of intermediates.

Products and Services

  • Pharmaceutical Formulations: Ortin Global Limited specializes in the production of a broad range of pharmaceutical formulations, including tablets, capsules, syrups, and dry powders. These formulations cover therapeutic areas such as anti-diabetics, anti-allergics, sedatives and tranquilisers, analgesics and antipyretics, antibiotics, antifungals, and cardiovascular medications, among others. The company's portfolio also features medications for treating helminthic infections, arthritis, and nutritional supplements including proteins, vitamins, and minerals.
  • Active Pharmaceutical Ingredient (API) Intermediates: The company manufactures API intermediates vital for the production of a wide array of medications. These include but are not limited to anti-retrovirals, anti-diabetics, analgesics, antibiotics, antifungals, antacids, and anti-malarials. Through its emphasis on quality and compliance, Ortin Global ensures that these intermediates meet the global pharmaceutical manufacturing standards.
  • Fine Chemicals: In addition to pharmaceutical products, Ortin Global produces fine chemicals, along with specialized compounds such as Grignard and alkali metal products. These chemicals serve as essential components in various industrial applications, highlighting the company’s diversification within the chemical manufacturing sector.
  • Services: Ortin Global provides a comprehensive suite of services catering to the pharmaceutical industry’s needs. These services include process development, wherein the company aids in developing and optimizing manufacturing processes for drugs and intermediates. Additionally, it offers product and process characterization, analytical research and development, assay development, and diagnostic services, which encompass the development of rapid flow kits, assays, and reagents. This extensive service offering underscores the company's commitment to supporting the pharmaceutical industry beyond mere product supply.
  • Contract Manufacturing and Export: The company also engages in long-term contracts for manufacturing intermediates and the development of new APIs, showcasing its capability in supporting large-scale pharmaceutical production. As a merchant exporter of pharmaceutical finished formulations, Ortin Global plays a crucial role in the global supply chain of medications, helping to meet the demand for pharmaceutical products in various international markets.

Contact Information

Address: D. No. 1-8-B4, F3 HIG
Phone: 91 40 2756 2055